An $11mclinical trial for a new treatment for women suffering from a loss of sexual desire has recently begun in New Zealand.
While the trial was in the pipeline pre-Covid, it foreshadows a growing trend of biotech and pharmaceutical companies choosing to operate their clinical trials in New
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).